|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Quality of life in hemodialysis, peritoneal dialysis, and transplantation patients显示文摘 | Sayin A Mutluay R Sindel S | 2007 | Transplant Proc2007，39，10： | 1 |
| 2 | Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery显示文摘 | Sayin MM Ozatamer O Tasoz R | 2002 | Br J Anaesth2002，89，： | 1 |
| 3 | Propofol attenu ares myo cardiallipid peroxidation during coronary artery bypass gra{ting surgery显示文摘 | Sayin MM Ozatamer O Tasoz R | 2002 | Br J Anaesth2002，89，： | 1 |
| 4 | Popofol attenuates myocardial lipid peroxidation during coronary artey bypass grafting surgery 显示文摘 | Sayin MM Ozatamer O Tasoz R | 2002 | Sr J Anaesth2002，89，2： | 1 |
| 5 | A level-crossing sampling scheme for A/D conversion 显示文摘 | SAYINER N SORENSEN H V VISWANATHAN T R | 1996 | IEEE Transactions on Circuits and Systems Ⅱ: Analog and Digital Signal Processing1996，43，4： | 1 |
| 6 | Quality of life in hemodialysis,peritoneal dialysis,and transplantation patients显示文摘 | Sayin A Mutluay R Sindel S | | 0，，10： | 1 |
| 7 | Quality of life in hemodialysis, peritoneal dialysis, and transplantation patients 显示文摘 | Sayin A Mufluay R Sindel S | 2007 | Transplantation Proceedings2007，37，10： | 1 |
| 8 | A levelcrossing sampling scheme for A/D conversion显示文摘 | Sayiner N Sorensen H V Viswanathan T R | 1996 | IEEE Trans on Circuits & Systems1996，43，4： | 1 |
| 9 | Quality of life in hemodialysis,peritoneal dialysis,and transplantation patients显示文摘 | Sayin A Mutluay R Sindel S | 2007 | Transplant Proc2007，39，10： | 1 |
| 10 | Popofol attenuates myocardial lipid peroxidation during coronary artey bypass grafting surgery显示文摘 | Sayin MM Ozatamer O Tasoz R | 2002 | Br J Anaesth2002，89，： | 1 |
| 11 | Popofol attenuates myocardial lipid peroxidation during coronary artey bypass grafting surgery显示文摘 | Ozatamer O Tasoz R | 2002 | Br J Anaesth2002，89，2： | 1 |
| 12 | Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery显示文摘 | Sayin MM Ozatamer O Tasoz R | 2002 | Br J Anaesth2002，89，2： | 1 |
| 13 | Comparison of two different treatment regimens’ efficacy in neovascular age-related macular degeneration in Turkish population—based on real life data-Bosphorus RWE Study Group显示文摘AIM: To compare two different anti-vascular endothelial growth factor(anti-VEGF) treatment regimens'-a priori pro re nata(PRN) and PRN regimen following^(th)e loading phaseanatomical and functional results in neovascular agerelated macular degeneration(n AMD) patients. METHODS: Totally 544 n AMD patients followed and treated with aflibercept(n=135) and ranibizumab(n=409)at 9 different centers between 2013 and 2015 were enrolled into^(th)is retrospective multicenter study. Patients with initial best corrected visual acuity(BCVA) interval of 1.3-0.3(log MAR) and a minimum follow-up of 12 mo were included. Patients under two different regimens-a priori pro re nata(1+PRN) or 3 consecutive intravitreal injections followed by a PRN regimen(3+PRN)-were compared in BCVA at 3^(th), 6^(th) and 12^(th) months, and in central macular^(th)ickness(CMT) at 6^(th) and 12^(th) months. The total study group, intravitreal ranibizumab(IVR) and intravitreal aflibercept(IVA) groups were evaluated separately. RESULTS: The mean CMT decreased in^(th)e 1+PRN(n=101) regimen from 407 to 358 and 340 μm and in^(th)e 3+PRN(n=443) group from 398 to 318 and finally to 310 μm at months 6 and 12, respectively. Anatomically,^(th)e CMT reduction at 6^(th) month(48.5 vs 76.4;P<0.05) was statistically significant in favor of 3+PRN group. BCVA changed in 1+PRN group from 0.77 to 0.78, 0.75 and 0.75;in 3+PRN group from 0.81 to 0.69, 0.72, and 0.76 at months 3, 6, and 12, respectively. Visual gain was statistically better in 3+PRN group at 3^(th) month(-0.01 vs 0.12;P<0.001). In IVR group, CMT reduction was in greater in 3+PRN at 6^(th)(44 vs 72) and 12^(th) month(61 vs 84), but statistically insignificant. The 3+PRN group revealed statistically better visual results at 3^(th) month(-0.02 vs 0.11, P<0.05). In IVA group, although statistically insignificant, CMT reduction(61 vs 89, 6^(th) month;85 vs 97, 12^(th) month) and visual gain(0.02 vs 0.16;0.02 vs 0.14;0.05 vs 0.11) was found in favor of 3+PRN group at all visits.CONCLUSION: The loading dose of anti-VEGF treatments in n AMD leads to significantly better anatomical and functional results, regardless of the agent, specially in early follow-up interval. | Burak Erden Selim Bolükbasi Abdullah Ozkaya Levent Karabas Cengiz Alagoz Zeynep Alkin Ozgür Artunay Sadik Etka Bayramoglu Gokhan Demir Mehmet Demir Ali Demircan Gürkan Erdogan Mehmet Erdogan Erdem Eris Havva Kaldirim Ismail Umut Onur Ozen Ayranci Osmanbasoglu Sezin Ozdogan Erkul Mine Oztürk Irfan Perente Kübra Sarici Nihat Sayin Dilek Yasa Ihsan Yilmaz Zeynep Yilmazabdurrahmanoglu 无 | 2020 | International Journal of Ophthalmology(English edition)2020，13，1： | 1 |
| 14 | Low-frequency repetitive transcra- nial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease 显示文摘 | Sayin S Cakmur R Yener GG | 2014 | J Clin Neu- rosei2014，21，8： | 1 |
| 15 | Guillain-barre syndrome following spinal anaesthesia显示文摘 | Sayin R Kati I Giines M | 2013 | J Coil Physicians Surg Pak2013，23，6： | 1 |
| 16 | Sneddon syndrome associated with protein S deficiency显示文摘 | SAYIN R BILGIL1 S G KARADAG A S | 2012 | Indian Journal of Der- matology Venereology & Leprology2012，78，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员